Breaking Walmart Shares Dip on Cautious Outlook Despite Strong Q2 Sales Pulitzer Prizes and ALA Launch Traveling Exhibition of Award-Winning Works Coventry City Earns Premier League Promotion After 25-Year Wait Democratic Party Narrows 2028 Convention Host City to Three Finalists Melting Glaciers Reveal Remains of Belgian Mountaineers Missing for Over 30 Years

Thursday August 20, 2026

Reporter

Teva Pharmaceutical Industries Ltd

3Articles Published

4Communities Covered

Published Articles

Press Release

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Aug 19

Press Release

Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

Aug 11

Press Release

Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Jul 29